TB-500
Thymosin Beta-4
A synthetic version of thymosin beta-4, a naturally occurring regenerative peptide found in virtually all human cells. Promotes wound healing, tissue repair, and reduces inflammation.
Typical Cost
$80-150/vial (5mg)
Status
Research
Peptide Profile
TB-500
Mechanism of Action
Upregulates actin, a cellular building protein essential for cell structure and movement. Promotes angiogenesis, wound healing, and tissue regeneration. Reduces inflammatory cytokines.
Common Dosages
subcutaneous
2-5mg
2x weekly · 4-8 weeks
subcutaneous (loading)
5-10mg
Weekly · 2 weeks, then maintenance
Benefits
Accelerated healing
Reduced inflammation
Improved flexibility
Tissue regeneration
Wound repair
Side Effects
Headache
Injection site reactions
Fatigue
Banned in sports
Key Research
TB-500 wound healing
Accelerated wound healing and tissue repair in animal models
TB-500 anti-inflammatory
Reduced inflammatory markers and cytokines
Regulatory Status
WADA-banned in sports. Not FDA-approved for human use. Veterinary use approved (Equine).
Contraindications
- ⚠Active cancer
- ⚠Pregnancy/breastfeeding
- ⚠Athletes subject to testing
GLP-1 users with injuries or tissue concerns may consider TB-500 alongside SeraVia formulations.
Learn More →Find peptide providers
Search 18,000+ clinics offering peptide therapy alongside GLP-1 medications.
Search Providers →Disclaimer: This information is for educational and research purposes only. Peptides described here may not be FDA-approved for human use. Always consult a qualified healthcare provider before using any peptide product. GLP1Search does not sell peptides.